Radar snapshot

37
Ingredients tracked
8
Fringe trends
5
Segments

Highest velocity signals this month

NMN — FDA reverses course, confirms lawful dietary ingredient status. NDIN still required.
DSHEA disclaimer reform — FDA signals rulemaking and grants enforcement discretion on label placement.
Xlear v. FTC — MAHA-aligned suit could flip the burden of proof on health claims industry-wide.
Postbiotics — shelf-stable formats open bars and beverages as new categories.

Current alerts

RedFTC v. Xlear substantiation challenge
RedLive it Up Super Greens Salmonella outbreak reopened
RedFTC contempt motion against Amare Global
AmberNMN lawful but NDIN still required
AmberMethylene blue biohacker use, no safety data
AmberMagnesium gummies recalled for undeclared melatonin
SignalDSHEA disclaimer enforcement discretion
SignalPostbiotics gain shelf-stable formulation flexibility

This edition

0 radar position changes — no prior baseline exists; this edition establishes initial signals only
6 new ingredients added — NMN, Postbiotics, Creatine (women's health), GLP-1 companion formulas, Ashwagandha, Methylene blue
8 new alerts — 3 red, 3 amber, 2 green